Fri, November 29, 2024

by: Thomas Matters

ChatGPT turns two: how has it impacted markets?

Two years on from ChatGPT's explosive launch into the public sphere, we assess the impact that it has had on stock markets and the world of technology

by: Thomas Matters

Here's how I'm investing in dividend shares to aim for long-term wealth

Our writer plans to turn investments in dividend shares into a retirement pot by implementing a structured, long-term approach.

by: Thomas Matters

Stock Market vs. CDs: Where's The Best Place to Park Your Cash?

It's an age-old debate, but the truth is that the best place for your money has a lot more to do with you than the vehicle. Read on to learn more.

by: Thomas Matters

The Fed is Losing the Inflation Battle. Investors Don't Care

Asset prices, meanwhile, have shrugged off all indication that the Fed's inflation battle is moving in the wrong direction. Stocks continue to hover at record highs, bond markets remain relatively unbothered, and bitcoin is still knocking on $100,000.

by: Thomas Matters

Prediction: Nvidia Stock Will Soar in 2025. Here's Why.

by: Thomas Matters

This Billionaire Investor Has Owned Palantir Since Its IPO. He Just Dumped Nearly His Entire Stake.

Palantir stock's growth occurred after the company reported accelerating revenue growth and expanding margin in every quarter this year. That growth can be attributed to its AI platform catching on with commercial customers and to the continued expansion of its government contracts, which is where Palantir first got its start.

by: Thomas Matters

Does Warren Buffett Buy Growth Stocks? These 2 Top Buffett Stocks Are Crushing the Market.

Warren Buffett is known for his value approach to investing, and that was on display again in Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) third-quarter trades. Both of these stocks fit the classic Buffett schema.

by: Thomas Matters

Dividends Are Never a Guarantee. These 3 Stocks Made Massive Cuts to Their Payouts This Year

Dividend stocks can be attractive options for long-term investors, in part, because of the recurring income they can generate. But investors need to remember that dividend payouts

by: Thomas Matters

Can I transfer a cash ISA to a stocks and shares ISA?

by: Thomas Matters

Should You Forget C3.ai and Buy These 2 AI Stocks Instead?

C3.ai is growing, but its business model might be unsustainable. Micron's sales of memory chips will rise as the AI market expands. IBM is carving out a defensible niche in the hybrid cloud and AI markets.

by: Thomas Matters

Investors Looking for Stability Tap South Africa in Trump Era

South Africa has long struggled with its reputation as a volatile and risky emerging market, but is now becoming a favorite among investors seeking to navigate a world with Donald Trump as the US president.

by: Thomas Matters

Scotia Global Asset Management announces fee reductions and year-end distribution estimates

by: Thomas Matters

Active momentum funds gather steam as large fund houses enter the fray

While the debate around active versus passive approach continues, both factions agree that momentum strategies come with inherent risks.

by: Thomas Matters

5 Mistakes to Avoid While Christmas Shopping at Costco This Year

Detailed price information for Costco Wholesale (COST-Q) from The Globe and Mail including charting and trades.

by: Thomas Matters

The Best Warren Buffett Stock to Buy With $500 Right Now

Investors shouldn't unthinkingly follow Buffett, or any other billionaire money manager, into Amazon or any other stock. However, Amazon is a top stock with robust opportunities trading at an attractive valuation, and if you have $500 available today, Amazon is an excellent choice.

by: Thomas Matters

7.7 million Australians are investing in ASX shares. Why aren't you?

That's the big question. The post 7.7 million Australians are investing in ASX shares. Why aren't you? appeared first on The Motley Fool Australia.

by: Thomas Matters

The Globe and Mail's 2024 Robo-Adviser Guide

Canada's major robo companies surveyed by The Globe and Mail generated after-fee returns ranging from 22 to 26 per cent in their growth portfolios for the year ended Sept. 30.

by: Thomas Matters

Bullish on Tesla, Apple, Nvidia? 4 ways to invest in international stocks

The foreign stock market can help investors diversify their investment portfolios. Furthermore, as an Indian investor, you can invest in international stocks through a variety of investment routes. Also,
Thu, November 28, 2024

by: Thomas Matters

What Happens To Your Money When A Mutual Fund Scheme Is Closed?

by: Thomas Matters

Embecta upgraded to Buy from Neutral at BTIG

by: Thomas Matters

MCAN Financial: Invested in Canadian Communities

by: Thomas Matters

Al Harper named to Rocky Mountain Chocolate Factory board of directors

by: Thomas Matters

Ripple's XRP could rally to $2.58 following a rise in whale buying activity

by: Thomas Matters

Analysis-Australia's Hot Jobs Market Keeps Rate Cuts Out of Reach

by: Thomas Matters

India's Defence Sector: Investing in Aatmanirbhar Push

by: Thomas Matters

3 Market-Beating ETFs for Large-, Mid-, and Small-Cap Exposure

by: Thomas Matters

How to Invest in Golden Goose Pre-IPO

by: Thomas Matters

Digital infrastructure, interconnected Grid, & affordable data made India most attractive investment destination: Piyush Goyal

by: Thomas Matters

Canadian Dollar catches a break from selling pressure on Wednesday

by: Thomas Matters

Adani Green Energy Says No Talks on New Financial Commitment With TotalEnergies

by: Thomas Matters

OFP Funding Review 2024: : Everything You Need to Know Before Signing Up

by: Thomas Matters

BMO ETFs: All-in-One Solutions for Simplified Investing

by: Thomas Matters

Dow Jones Industrial Average ends Wednesday lower despite tapping record bid

by: Thomas Matters

European Stocks off Two-Week Highs as Energy Stocks Weigh

by: Thomas Matters

49-Year-Old Makes $5,180 a Month in Dividends With 'Helps Me Sleep at Night' Portfolio - Top 10 Stocks You Can't Miss

Wed, November 27, 2024

by: Thomas Matters

Is Tesla a better opportunity than Indian automakers?

by: Thomas Matters

Here's Why Momentum in Vertiv (VRT) Should Keep going

by: Thomas Matters

Gold funds vs ETFs: Which one should investors choose now?

by: Thomas Matters

Stock market today: S&P 500, Nasdaq slide after key Fed inflation gauge shows faltering progress

by: Thomas Matters

Stocks slip the day before Thanksgiving as Nvidia, Dell decline: Live updates

by: Thomas Matters

Sudarshan Chemical shares in focus after promoters sell stake via block deals

by: Thomas Matters

Quantum Computing: I Don't Expect Big Revenues Until 2030+

by: Thomas Matters

Consumer Spending Powers Q3 US GDP Growth to 2.8%

by: Thomas Matters

Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood?

by: Thomas Matters

Consumer-Related Stocks Help Lift TSX to Record Closing High

by: Thomas Matters

Japanese Yen and Australian Dollar News: Will Yen Break 50 on BoJ Rate Hike Signals?

by: Thomas Matters

USD/JPY: Oversold conditions can bush the USD downwards - UOB Group

by: Thomas Matters

Russian Central Bank Intervenes as Rouble Tumbles Past 0 to the Dollar

Is Pfizer Stock in Trouble?

One stock that just can't seem to catch a break of late is Pfizer (NYSE: PFE). Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 billion in 2022),

The article from AOL discusses the challenges faced by Pfizer Inc. as its stock has experienced a significant decline, dropping by 30% in the past year. This downturn is attributed to several factors including the waning demand for its COVID-19 vaccine and treatment, Comirnaty and Paxlovid, as the global health crisis transitions into an endemic phase. Additionally, Pfizer is dealing with patent expirations, increased competition from generic drugs, and a broader market shift away from pharmaceutical stocks. The company's efforts to diversify its portfolio through acquisitions and new product development are highlighted, but these initiatives have not yet offset the revenue loss from its blockbuster drugs. The article also touches on the broader implications for investors, suggesting that while Pfizer faces immediate headwinds, its long-term strategy might still hold promise if new products gain traction.

Read the Full AOL Article at https://www.aol.com/pfizer-stock-trouble-111700534.html